Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Walgreens Boots Alliance Inc    

End-of-day quote. End-of-day quote  - 02/09
76.4 USD   +12.60%
07/21DJTheranos Hires Compliance, Regulatory Executives
07/18DJStarbucks Widens Workers' Health-Insurance Options
07/13DJWALGREENS BOOTS : Boosts Its Quarterly Dividend 4.2%
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Walgreen Company : Walgreen April Same-Store Sales Fall Bigger-Than-Expected 6.4%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 02:39pm CEST

Walgreen Co.'s (WAG) April same-store sales fell a bigger-than-expected 6.4%--marking the fourth straight month of declines--as the drug-store chain's loss of Express Scripts Holding Co.'s (ESRX) members continued to hamper results.

Analysts polled by Thomson Reuters expected April same-store sales to fall 5.1%.

A conflict between Walgreen and Express Scripts over new contract terms erupted publicly last June, and Walgreen said it wouldn't be part of the pharmacy-benefits manager's network when their deal expired in 2011. The benefit manager's clients now have to go elsewhere to fill prescriptions.

Total sales fell 3.7% to $5.78 billion last month.

April same-pharmacy sales decreased 8.9% and missed the analysts' projected 8.6% decline.

Total pharmacy sales fell 6.3%. Prescriptions filled at same-stores declined 7.8% in April, reflecting the loss of Express Scripts members, a lower incidence of flu and more generic drug introductions. Prescriptions processed by Express Scripts comprised 12.6% of Walgreen's prescriptions a year earlier.

In the front of the store, same-store sales slipped fell 2.2% last month, compared with the analysts' flat front-end same-store sales forecast.

Total front-end sales slipped 0.5%. Customer traffic at same-stores fell 3% and average basket size increased 0.8%.

Walgreen reported in March its fiscal second-quarter earnings fell 7.7% as its exit from Express Scripts's network and a mild cold and flu season offset a 0.8% pop in total sales.

Shares closed Wednesday at $34.15 and were inactive premarket. The stock has gained 3.3% since the beginning of the year.

-By Melodie Warner, Dow Jones Newswires; 212-416-2283; melodie.warner@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE I
07/21 WALGREENS BOOTS ALLIANCE : Increases Quarterly Dividend
07/21DJTheranos Hires Compliance, Regulatory Executives
07/18DJStarbucks Widens Workers' Health-Insurance Options
07/13DJWALGREENS BOOTS ALLIANCE : Boosts Its Quarterly Dividend 4.2%
07/13DJWALGREENS BOOTS ALLIANCE : Boosts Its Quarterly Dividend 4.2%
07/13 WALGREENS BOOTS ALLIANCE : Increases Quarterly Dividend
07/13DJConAgra Names CEO, Chairman of Potato Business Spinoff
07/08DJAMGEN : Theranos Dealt Blow as Holmes Is Banned From -2-
07/08DJAMGEN : Theranos Dealt Blow as Holmes Is Banned From Operating Labs
07/07 WALGREENS : to Participate in U.S. Precision Medicine Initiative Cohort Program ..
More news
Sector news : Drug Retailers - NEC
07/21 MCKESSON : Theranos hires executives in regulatory, compliance push
07/21DJTheranos Hires Compliance, Regulatory Executives
07/21DJSINOPHARM : to Inject Certain Assets Into China National Medicines for CNY5.37 B..
07/07DJWALGREENS BOOTS ALLIANCE : Warns Of U.K. Uncertainty -- WSJ
07/06DJWALGREENS BOOTS ALLIANCE : Warns of Uncertainty in the U.K.-- 2nd Update
More sector news : Drug Retailers - NEC
Advertisement
Financials ($)
Sales 2016 117 901 M
EBIT 2016 6 964 M
Net income 2016 4 050 M
Debt 2016 10 256 M
Yield 2016 1,77%
P/E ratio 2016 21,61
P/E ratio 2017 17,57
EV / Sales 2016 0,83x
EV / Sales 2017 0,80x
Capitalization 88 047 M
More Financials
Chart WALGREENS BOOTS ALLIANCE I
Duration : Period :
Walgreens Boots Alliance I Technical Analysis Chart | US9314221097 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 93,0 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
George Rollo Fairweather Global Chief Financial Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIAN..-0.07%88 047
CVS HEALTH CORP-1.25%103 697
WALGREENS BOOTS ALLIAN..-4.47%88 047
EXPRESS SCRIPTS HOLDIN..-9.78%49 903
MCKESSON CORPORATION-0.33%44 365
CARDINAL HEALTH INC-7.03%27 039
More Results